Strasbourg, France<\/b> \u2013 Toda Pharma, a major player in the field of rapid diagnostic tests, made its presence felt at the Pr\u00e9ventica Strasbourg trade show<\/b>, held from June 18 to 20, 2024. This unmissable event, dedicated to health, safety, and quality of life at work, was an opportunity for Toda Pharma to unveil its new flagship product: the Toda Drugdiag® Saliva Innovation<\/b>.<\/p>\r\nPresentation of the Toda Drugdiag® Saliva Innovation<\/h2>\r\n
At the heart of our participation this year, the Toda Drugdiag® Saliva Innovation<\/b> generated a great deal of interest. This saliva drug screening test stands out for its speed<\/b>, reliability<\/b>, as well as its ergonomics<\/b> and ease of use<\/b>. Designed to meet the needs of businesses, healthcare professionals, and institutions, this test detects the presence of illicit substances in minutes, providing a valuable tool for ensuring workplace safety.<\/p>\r\nA fast and reliable test<\/h2>\r\n
The Toda Drugdiag® Saliva Innovation<\/b> is positioned as a premier solution for drug screening. Thanks to its advanced technology, this test delivers accurate results in less than 10 minutes, allowing safety and health managers to make informed decisions quickly. Its reliability has been tested and validated through rigorous studies, ensuring optimal performance under various operating conditions.<\/p>\r\nErgonomic and easy to use<\/h2>\r\n
Designed for simple and intuitive operation, the Toda Drugdiag® Saliva Innovation<\/b> is ergonomic and requires no prior training for effective use. The testing process is quick and non-invasive: simply take a saliva sample, insert the strip into the device, and wait a few minutes for the result. This ease of use makes it an ideal tool for companies looking to implement screening measures without complexity.<\/p>\r\nAn enthusiastic welcome at the Pr\u00e9ventica Show<\/h2>\r\n
Visitors to the Pr\u00e9ventica Strasbourg show<\/b> enthusiastically welcomed the Toda Drugdiag® Saliva Innovation. Many safety professionals, business leaders, and occupational health specialists expressed great interest in this innovative test. Live demonstrations highlighted the simplicity and effectiveness of the device, confirming its potential to improve workplace safety.<\/p>\r\nPresence of Cyrille Coton, CEO and trainer of SAFE UP<\/h2>\r\n
During this exhibition, we also had the honor of welcoming Cyrille Coton<\/b>, representing SAFE UP<\/b>, our strategic partner in the distribution of workplace safety solutions. His presence at our booth allowed us to further discuss current challenges in corporate safety and to jointly present how the Toda Drugdiag\u00ae Saliva Innovation can be integrated into comprehensive prevention strategies. The discussions with Cyrille Coton enriched the discussions, strengthening the collaboration between SAFE UP<\/b> and Toda Pharma<\/b> to offer comprehensive and effective solutions to occupational safety professionals.<\/p>\r\nConclusion<\/h2>\r\n
Toda Pharma’s participation in the Pr\u00e9ventica Strasbourg 2024 trade show<\/b> was a resounding success, with a successful presentation of the Toda Drugdiag® Saliva Innovation. This fast, reliable, and easy-to-use saliva test has established itself as an essential tool for drug screening in the workplace. We thank all the visitors who came to discover our innovation, and we remain at their disposal for any additional information or partnership requests.
To learn more about the Toda Drugdiag® Saliva Innovation or to contact us, visit our website or follow us on social media.<\/p>","protected":false},"excerpt":{"rendered":"Strasbourg, France \u2013 Toda Pharma, a major player in the field of rapid diagnostic tests, made its presence felt at the Pr\u00e9ventica Strasbourg trade show, held from June 18 to 20, 2024. This unmissable event, dedicated to health, safety, and quality of life at work, was an opportunity for Toda Pharma to unveil its new […]","protected":false},"author":1,"featured_media":3153,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[113,109],"tags":[],"class_list":["post-4175","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-events"],"acf":[],"_links":{"self":[{"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/posts\/4175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/comments?post=4175"}],"version-history":[{"count":4,"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/posts\/4175\/revisions"}],"predecessor-version":[{"id":4185,"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/posts\/4175\/revisions\/4185"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/media\/3153"}],"wp:attachment":[{"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/media?parent=4175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/categories?post=4175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wst.todapharma.com\/en\/wp-json\/wp\/v2\/tags?post=4175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}